μsmin® Plus is an innovative diosmin formulation (>80% pure diosmin and 90% total flavonoids) derived from hesperidin found in bitter orange (Citrus aurantium L) that demonstrates enhanced absorption and bioavailability compared to standard micronized diosmin.
In a double-blind, crossover study, smin Plus showed greater plasma concentration and 9.4 times greater bioavailability compared to standard micronized diosmin.
Today Giellepi is pleased to announce the publication of a new clinical study on smin® Plus (Microsmin Plus), titled “Efficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial”. The results published in Nutrients further strengthen smin® Plus’ superiority in the diosmin marketplace showing dramatic improvements in leg circumference, quality of life (QOL), leg pain and common symptoms associated to Chronic Venous Disease (CVD).
In t
| UPDATED: 15:33, Mon, Dec 21, 2020
Link copied Sign up for FREE health tips to live a long and happy life
SUBSCRIBE Invalid email
When you subscribe we will use the information you provide to send you these newsletters.
Sometimes they ll include recommendations for other related newsletters or services we offer.
Our Privacy Notice explains more about how we use your data, and your rights.
You can unsubscribe at any time.
Work from home has become a reality for millions of Brits this year, who had to adapt or risk losing their jobs. Avoiding the commute is a vital tool in preventing Covid-19, as the crowds provide a range of opportunities to contract the disease. But the sedentary lifestyles many people now lead comes with a selection of its own risks, especially when it comes to venous health.